These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21055930)

  • 1. Antiangiogenic properties of substituted (Z)-(±)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-ol/one analogs and their derivatives.
    Venkateswaran A; Reddy YT; Sonar VN; Muthusamy V; Crooks PA; Freeman ML; Sekhar KR
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7323-6. PubMed ID: 21055930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel substituted (Z)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-one and (Z)-(+/-)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-ol derivatives as potent thermal sensitizing agents.
    Sonar VN; Thirupathi Reddy Y; Sekhar KR; Sasi S; Freeman ML; Crooks PA
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6821-4. PubMed ID: 17980582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel antiangiogenic VJ115 inhibits the NADH oxidase ENOX1 and cytoskeleton-remodeling proteins.
    Venkateswaran A; Friedman DB; Walsh AJ; Skala MC; Sasi S; Rachakonda G; Crooks PA; Freeman ML; Sekhar KR
    Invest New Drugs; 2013 Jun; 31(3):535-44. PubMed ID: 23054211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indolyl-quinuclidinols inhibit ENOX activity and endothelial cell morphogenesis while enhancing radiation-mediated control of tumor vasculature.
    Geng L; Rachakonda G; Morré DJ; Morré DM; Crooks PA; Sonar VN; Roti JL; Rogers BE; Greco S; Ye F; Salleng KJ; Sasi S; Freeman ML; Sekhar KR
    FASEB J; 2009 Sep; 23(9):2986-95. PubMed ID: 19395476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aplysinopsin analogs: Synthesis and anti-proliferative activity of substituted (Z)-5-(N-benzylindol-3-ylmethylene)imidazolidine-2,4-diones.
    Thirupathi Reddy Y; Narsimha Reddy P; Koduru S; Damodaran C; Crooks PA
    Bioorg Med Chem; 2010 May; 18(10):3570-4. PubMed ID: 20403701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Heteroaryl-substituted quinuclidin-3-ol and quinuclidin-2-ene derivatives as muscarinic antagonists. Synthesis and structure-activity relationships.
    Nilsson BM; Sundquist S; Johansson G; Nordvall G; Glas G; Nilvebrant L; Hacksell U
    J Med Chem; 1995 Feb; 38(3):473-87. PubMed ID: 7853341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of novel meta- and para-substituted N-benzyl protected quinuclidine esters and their resolution with butyrylcholinesterase.
    Primožič I; Bolant M; Ramić A; Tomić S
    Molecules; 2012 Jan; 17(1):786-95. PubMed ID: 22249408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonists.
    Clark RD; Miller AB; Berger J; Repke DB; Weinhardt KK; Kowalczyk BA; Eglen RM; Bonhaus DW; Lee CH; Michel AD
    J Med Chem; 1993 Sep; 36(18):2645-57. PubMed ID: 8410977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of (Z)-2-((1-benzyl-1H-indol-3-yl)methylene)-quinuclidin-3-one analogues as novel, high affinity ligands for CB1 and CB2 cannabinoid receptors.
    Madadi NR; Penthala NR; Brents LK; Ford BM; Prather PL; Crooks PA
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2019-21. PubMed ID: 23466226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
    Naito R; Yonetoku Y; Okamoto Y; Toyoshima A; Ikeda K; Takeuchi M
    J Med Chem; 2005 Oct; 48(21):6597-606. PubMed ID: 16220976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center.
    Hotchkiss KA; Ashton AW; Mahmood R; Russell RG; Sparano JA; Schwartz EL
    Mol Cancer Ther; 2002 Nov; 1(13):1191-200. PubMed ID: 12479700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
    Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
    Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Oncol Rep; 2005 Dec; 14(6):1399-404. PubMed ID: 16273231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
    Cao ZX; Zheng RL; Lin HJ; Luo SD; Zhou Y; Xu YZ; Zeng XX; Wang Z; Zhou LN; Mao YQ; Yang L; Wei YQ; Yu LT; Yang SY; Zhao YL
    Cell Physiol Biochem; 2011; 27(5):565-74. PubMed ID: 21691074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4',5-trimethoxylstilbene-3'-O-phosphate disodium (M410).
    Cai YC; Zou Y; Ye YL; Sun HY; Su QG; Wang ZX; Zeng ZL; Xian LJ
    Invest New Drugs; 2011 Apr; 29(2):300-11. PubMed ID: 20012336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
    Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
    J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and anti-proliferative evaluation of [1,1'-biphenyl]-4-ols as inhibitor of HUVEC migration and tube formation.
    Ran Y; Ma L; Wang X; Chen J; Wang G; Peng A; Chen L
    Molecules; 2012 Jul; 17(7):8091-104. PubMed ID: 22766801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of symmetrical bis-alkynyl or alkyl pyridine and thiophene derivatives and their antiangiogenic activities.
    Ahn CM; Shin WS; Bum Woo H; Lee S; Lee HW
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3893-6. PubMed ID: 15225692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformation-activity relationship on novel 4-pyridylmethylthio derivatives with antiangiogenic activity.
    Honda T; Tajima H; Kaneko Y; Ban M; Inaba T; Takeno Y; Okamoto K; Aono H
    Bioorg Med Chem Lett; 2008 May; 18(9):2939-43. PubMed ID: 18420406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
    Ma L; Chen J; Wang X; Liang X; Luo Y; Zhu W; Wang T; Peng M; Li S; Jie S; Peng A; Wei Y; Chen L
    J Med Chem; 2011 Oct; 54(19):6469-81. PubMed ID: 21853991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.